中国医药
中國醫藥
중국의약
China Medicine
2015年
10期
1485-1489
,共5页
胶原诱导性关节炎%蒙药森登%干扰素γ%白细胞介素4
膠原誘導性關節炎%矇藥森登%榦擾素γ%白細胞介素4
효원유도성관절염%몽약삼등%간우소γ%백세포개소4
Collagen induced arthritis%Mongolian medicine Senden Decoction%Interferon γ%Interleukin 4
目的 探讨蒙药森登对胶原诱导性关节炎(CIA)模型大鼠干扰素γ和白细胞介素4(IL-4)表达的影响.方法 将60只大鼠完全随机分为正常组、模型组、雷公藤多苷组[9.45 mg/(kg·d)]和蒙药森登汤低、中、高剂量组[1.35、2.70、5.40 g/(kg·d)],每组30只,采用胶原诱导方法建立大鼠免疫性关节炎模型.各治疗组于造模后第12天开始灌胃给药,正常组和模型组同期灌胃等体积蒸馏水,1次/d,疗程28 d.于造模前(0 d)、治疗前(开始造模后10 d)及治疗后(开始造模后20、30、40 d)观察大鼠一般情况、测量后足掌厚度、评估关节炎指数;疗程结束后,采用酶联免疫吸附法检测血清干扰素γ和IL-4水平,计算干扰素γ/IL-4比值,采用免疫组织化学方法检测踝关节中干扰素γ和IL-4的表达水平.结果 模型组大鼠一般情况差,各治疗组大鼠一般情况优于模型组.20、30、40 d时点雷公藤多苷组和蒙药森登汤低、中、高剂量组大鼠足掌厚度变化均低于模型组,差异有统计学意义[20d:(4.06±0.04)、(4.31±0.03)、(4.24±0.03)、(4.24 ±0.03)mm比(4.47±0.04)mm;30 d:(4.69±0.04)、(3.99±0.06)、(3.86±0.04)、(3.81±0.04)mm比(4.45±0.04)mm;40 d:(4.56±0.03)、(3.94±0.05)、(3.74 ±0.04)、(3.65±0.02)mm比(4.38±0.03)mm] (P <0.01),其中雷公藤多苷组和蒙药森登汤高剂量组与蒙药森登汤低剂量组比较差异有统计学意义(P<0.01).20、30、40 d时点雷公藤多苷组和蒙药森登汤低、中、高剂量组大鼠关节炎指数均低于模型组,差异有统计学意义[20 d:(8.2±1.4)、(8.9±1.1)、(8.3±1.3)、(8.8±1.7)分比(10.9±1.3)分;30 d:(6.2±1.3)、(7.7±1.3)、(7.1±1.1)、(7.3±1.2)分比(9.7±1.2)分;40 d:(4.1±0.9)、(6.8±1.3)、(6.1±1.0)、(5.2±1.3)分比(8.9±0.7)分](P<0.05或P<0.01),其中雷公藤多苷组和蒙药森登汤高剂量组与蒙药森登汤低剂量组比较差异有统计学意义(P<0.01).模型组血清干扰素γ水平明显高于正常组[(396±30) ng/L比(238±36) ng/L],雷公藤多苷组和蒙药森登汤低、中、高剂量组干扰素γ水平均明显低于模型组[(251±36)、(323±51)、(295±24)、(258±23) ng/L比(396±30) ng/L] (P<0.01);各组间血清IL-4含量差异无统计学意义(P>0.05).模型组血清干扰素γ/IL-4明显高于正常组[(28.5±3.2)比(19.4±4.2)],雷公藤多苷组和蒙药森登汤中、高剂量组干扰素γ/IL-4明显低于模型组[(21.1±4.3)、(22.1±2.0)、(21.4±2.6)比(28.5±3.2)](P<0.01).模型组踝关节干扰素γ和IL-4表达水平明显高于正常组[(8.4±2.3)分比(2.1±0.8)分,(7.5±1.2)分比(1.8±0.7)分],雷公藤多苷组和蒙药森登汤中、高剂量组干扰素γ表达水平明显低于模型组[(3.6±2.1)、(5.4±2.3)、(3.7±2.1)分比(8.4±2.3)分],雷公藤多苷组和蒙药森登汤高剂量组IL-4表达水平明显低于模型组[(2.1±0.9)、(3.8±1.4)分比(7.5±1.2)分](P<0.01).结论 蒙药森登能够改善CIA模型大鼠一般情况及关节炎症状,降低干扰素γ、IL-4的表达水平,高剂量疗效与阳性对照药雷公藤多苷相当.
目的 探討矇藥森登對膠原誘導性關節炎(CIA)模型大鼠榦擾素γ和白細胞介素4(IL-4)錶達的影響.方法 將60隻大鼠完全隨機分為正常組、模型組、雷公籐多苷組[9.45 mg/(kg·d)]和矇藥森登湯低、中、高劑量組[1.35、2.70、5.40 g/(kg·d)],每組30隻,採用膠原誘導方法建立大鼠免疫性關節炎模型.各治療組于造模後第12天開始灌胃給藥,正常組和模型組同期灌胃等體積蒸餾水,1次/d,療程28 d.于造模前(0 d)、治療前(開始造模後10 d)及治療後(開始造模後20、30、40 d)觀察大鼠一般情況、測量後足掌厚度、評估關節炎指數;療程結束後,採用酶聯免疫吸附法檢測血清榦擾素γ和IL-4水平,計算榦擾素γ/IL-4比值,採用免疫組織化學方法檢測踝關節中榦擾素γ和IL-4的錶達水平.結果 模型組大鼠一般情況差,各治療組大鼠一般情況優于模型組.20、30、40 d時點雷公籐多苷組和矇藥森登湯低、中、高劑量組大鼠足掌厚度變化均低于模型組,差異有統計學意義[20d:(4.06±0.04)、(4.31±0.03)、(4.24±0.03)、(4.24 ±0.03)mm比(4.47±0.04)mm;30 d:(4.69±0.04)、(3.99±0.06)、(3.86±0.04)、(3.81±0.04)mm比(4.45±0.04)mm;40 d:(4.56±0.03)、(3.94±0.05)、(3.74 ±0.04)、(3.65±0.02)mm比(4.38±0.03)mm] (P <0.01),其中雷公籐多苷組和矇藥森登湯高劑量組與矇藥森登湯低劑量組比較差異有統計學意義(P<0.01).20、30、40 d時點雷公籐多苷組和矇藥森登湯低、中、高劑量組大鼠關節炎指數均低于模型組,差異有統計學意義[20 d:(8.2±1.4)、(8.9±1.1)、(8.3±1.3)、(8.8±1.7)分比(10.9±1.3)分;30 d:(6.2±1.3)、(7.7±1.3)、(7.1±1.1)、(7.3±1.2)分比(9.7±1.2)分;40 d:(4.1±0.9)、(6.8±1.3)、(6.1±1.0)、(5.2±1.3)分比(8.9±0.7)分](P<0.05或P<0.01),其中雷公籐多苷組和矇藥森登湯高劑量組與矇藥森登湯低劑量組比較差異有統計學意義(P<0.01).模型組血清榦擾素γ水平明顯高于正常組[(396±30) ng/L比(238±36) ng/L],雷公籐多苷組和矇藥森登湯低、中、高劑量組榦擾素γ水平均明顯低于模型組[(251±36)、(323±51)、(295±24)、(258±23) ng/L比(396±30) ng/L] (P<0.01);各組間血清IL-4含量差異無統計學意義(P>0.05).模型組血清榦擾素γ/IL-4明顯高于正常組[(28.5±3.2)比(19.4±4.2)],雷公籐多苷組和矇藥森登湯中、高劑量組榦擾素γ/IL-4明顯低于模型組[(21.1±4.3)、(22.1±2.0)、(21.4±2.6)比(28.5±3.2)](P<0.01).模型組踝關節榦擾素γ和IL-4錶達水平明顯高于正常組[(8.4±2.3)分比(2.1±0.8)分,(7.5±1.2)分比(1.8±0.7)分],雷公籐多苷組和矇藥森登湯中、高劑量組榦擾素γ錶達水平明顯低于模型組[(3.6±2.1)、(5.4±2.3)、(3.7±2.1)分比(8.4±2.3)分],雷公籐多苷組和矇藥森登湯高劑量組IL-4錶達水平明顯低于模型組[(2.1±0.9)、(3.8±1.4)分比(7.5±1.2)分](P<0.01).結論 矇藥森登能夠改善CIA模型大鼠一般情況及關節炎癥狀,降低榦擾素γ、IL-4的錶達水平,高劑量療效與暘性對照藥雷公籐多苷相噹.
목적 탐토몽약삼등대효원유도성관절염(CIA)모형대서간우소γ화백세포개소4(IL-4)표체적영향.방법 장60지대서완전수궤분위정상조、모형조、뢰공등다감조[9.45 mg/(kg·d)]화몽약삼등탕저、중、고제량조[1.35、2.70、5.40 g/(kg·d)],매조30지,채용효원유도방법건립대서면역성관절염모형.각치료조우조모후제12천개시관위급약,정상조화모형조동기관위등체적증류수,1차/d,료정28 d.우조모전(0 d)、치료전(개시조모후10 d)급치료후(개시조모후20、30、40 d)관찰대서일반정황、측량후족장후도、평고관절염지수;료정결속후,채용매련면역흡부법검측혈청간우소γ화IL-4수평,계산간우소γ/IL-4비치,채용면역조직화학방법검측과관절중간우소γ화IL-4적표체수평.결과 모형조대서일반정황차,각치료조대서일반정황우우모형조.20、30、40 d시점뢰공등다감조화몽약삼등탕저、중、고제량조대서족장후도변화균저우모형조,차이유통계학의의[20d:(4.06±0.04)、(4.31±0.03)、(4.24±0.03)、(4.24 ±0.03)mm비(4.47±0.04)mm;30 d:(4.69±0.04)、(3.99±0.06)、(3.86±0.04)、(3.81±0.04)mm비(4.45±0.04)mm;40 d:(4.56±0.03)、(3.94±0.05)、(3.74 ±0.04)、(3.65±0.02)mm비(4.38±0.03)mm] (P <0.01),기중뢰공등다감조화몽약삼등탕고제량조여몽약삼등탕저제량조비교차이유통계학의의(P<0.01).20、30、40 d시점뢰공등다감조화몽약삼등탕저、중、고제량조대서관절염지수균저우모형조,차이유통계학의의[20 d:(8.2±1.4)、(8.9±1.1)、(8.3±1.3)、(8.8±1.7)분비(10.9±1.3)분;30 d:(6.2±1.3)、(7.7±1.3)、(7.1±1.1)、(7.3±1.2)분비(9.7±1.2)분;40 d:(4.1±0.9)、(6.8±1.3)、(6.1±1.0)、(5.2±1.3)분비(8.9±0.7)분](P<0.05혹P<0.01),기중뢰공등다감조화몽약삼등탕고제량조여몽약삼등탕저제량조비교차이유통계학의의(P<0.01).모형조혈청간우소γ수평명현고우정상조[(396±30) ng/L비(238±36) ng/L],뢰공등다감조화몽약삼등탕저、중、고제량조간우소γ수평균명현저우모형조[(251±36)、(323±51)、(295±24)、(258±23) ng/L비(396±30) ng/L] (P<0.01);각조간혈청IL-4함량차이무통계학의의(P>0.05).모형조혈청간우소γ/IL-4명현고우정상조[(28.5±3.2)비(19.4±4.2)],뢰공등다감조화몽약삼등탕중、고제량조간우소γ/IL-4명현저우모형조[(21.1±4.3)、(22.1±2.0)、(21.4±2.6)비(28.5±3.2)](P<0.01).모형조과관절간우소γ화IL-4표체수평명현고우정상조[(8.4±2.3)분비(2.1±0.8)분,(7.5±1.2)분비(1.8±0.7)분],뢰공등다감조화몽약삼등탕중、고제량조간우소γ표체수평명현저우모형조[(3.6±2.1)、(5.4±2.3)、(3.7±2.1)분비(8.4±2.3)분],뢰공등다감조화몽약삼등탕고제량조IL-4표체수평명현저우모형조[(2.1±0.9)、(3.8±1.4)분비(7.5±1.2)분](P<0.01).결론 몽약삼등능구개선CIA모형대서일반정황급관절염증상,강저간우소γ、IL-4적표체수평,고제량료효여양성대조약뢰공등다감상당.
Objective To explore the effect of Mongolian medicine Senden decoction on expression of interferon (IFN) γ and interleukin (IL) 4 in collagen induced arthrtitis (CIA) rat model.Methods The CIA model was incuced by collagen.Sixty rats were randomly divided into normal group,model group,tripterygium glycosides group [9.45 mg/(kg · d)],Mongolian medicine low,middle and high dose group [1.35,2.70,5.40 g/(kg· d)].The therapy groups were given intragastric administration of drugs on the 12th day after establishment of CIA model (1 time/d,last for 28 d).Before establishment of CIA model (0 d),before therapy (10 d) and after therapy (20,30,40 d),the general conditions of the rat were observed;the thickness of hind plantar was measured and the arthritis index was assessed.At the end of therapy,the levels of IFN-γand IL-4 in serum were measured by enzyme linked immunosorbent assay;the expressions of IFN-γ and IL-4 in the ankle joint were assessed by immunohistochemistry.Results The general conditions of the rats in model group were bad and they were improved in four therapy groups.At 20,30 and 40 d time points,the thickness of hind paw in tripterygium glycosides group,Mongolian medicine low,middle and high dose group was significantly lower than that in model group[20 d:(4.06 ±0.04),(4.31 ±0.03),(4.24 ±0.03),(4.24 ±0.03) mm vs (4.47 ± 0.04) mm;30 d:(4.69 ±±0.04),(3.99 ±0.06),(3.86 ±0.04),(3.81 ±0.04) mm vs (4.45 ±0.04) mm;40 d:(4.56 ±0.03),(3.94 ±0.05),(3.74 ±0.04),(3.65 ±0.02) mm vs (4.38 ±0.03) mm] (P < 0.01);the thickness of hind paw in tripterygium glycosides group and Mongolian medicine high dose group was significantly lower than that in Mongolian medicine low dose group (P < 0.01).At 20,30 and 40 d time points,the arthritis indexes in tripterygium glycosides group,Mongolian medicine low,middle and high dose group were all significantly lower than those in model group [20 d:(8.2 ± 1.4),(8.9 ± 1.1),(8.3 ±1.3),(8.8 ±1.7) scoresvs (10.9 ±1.3) scores,30d:(6.2 ±1.3),(7.7±1.3),(7.1 ±1.1),(7.3±1.2) scores vs (9.7±1.2) scores,40d:(4.1 ±0.9),(6.8±l.3),(6.1 ±1.0),(5.2±1.3) scores vs (8.9 ±0.7) scores] (P <0.05 or P <0.01);the arthritis indexes in tripterygium glycosides group and Mongolian medicine high dose group were significantly lower than those in Mongolian medicine low dose group (P <0.01).The level of IFN-γin serum in model group was significantly higher than that in normal group [(396 ±30) ng/L vs (238 ± 36) ng/L];it was significantly decreased in tripterygium glycosides group,Mongolian medicine low,middle and high dose group [(251 ±36),(323 ±51),(295 ±24),(258 ±23) ng/L vs (396 ±30) ng/L] (P <0.01);no differences of IL-4 level were found among all groups (P >0.05);the ratio of IFN-γ/IL-4 in model group was significantly higher than that in normal group [(28.5 ±3.2) vs (19.4 ±4.2)];it was significantly decreased in tripterygium glycosides group,Mongolian medicine middle and high dose group [(21.1±4.3),(22.1±2.0),(21.4±2.6) vs (28.5 ±3.2)] (P<0.01).The expressions ofIFN-γ and IL-4 in model group were significantly higher than those in normal group [(8.4 ± 2.3) scores vs (2.1 ±0.8) scores,(7.5 ± 1.2) scores vs (1.8 ± 0.7) scores];in tripterygium glycosides group,Mongolian medicine middle and high dose group,the expression of IFN-γ was significantly lower than that in model group [(3.6 ±2.1),(5.4 ± 2.3),(3.7 ± 2.1) scores vs (8.4 ± 2.3) scores];in tripterygium glycosides group and Mongolian medicine high dose group,the expression of IL-4 was significantly lower than that in model group [(2.1 ± 0.9),(3.8 ± 1.4) scores vs (7.5 ± 1.2) scores] (P < 0.01).Conclusion Mongolian medicine Senden decoction can improve the general conditions and symptoms of arthritis in CIA rats and reduce the the expressions of IFN-γ and IL-4,with similar effect at high dose compared with tripterygium glycosides.